We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$61.5B
1-Year Est. Return
30.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+30.7%
3 Year Est. Return
+96.89%
5 Year Est. Return
+121.97%
10 Year Est. Return
+542.41%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$1.09B
Cap. Flow
% of AUM
-2.71%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.13% |
| 2 | Technology | 18.75% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.88% |
| 5 | Communication Services | 7.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Bristol-Myers Squibb
BMY
$129B
| $149M | 0.37% |
2,539,713
+2,398,525
| +1,699% | +$143M |
|
|
52
3M
MMM
$93.1B
| $149M | 0.37% |
1,141,283
+1,129,444
| +9,540% | +$142M |
|
53
Roper Technologies
ROP
$39.8B
| $147M | 0.36% |
379,004
-46,142
| -11% | -$16.5M |
|
54
Mastercard
MA
$498B
| $146M | 0.36% |
492,179
-38,793
| -7% | -$10.9M |
|
55
Agnico Eagle Mines
AEM
$70.1B
| $144M | 0.36% |
2,250,626
-28,400
| -1% | -$1.68M |
|
56
GDS Holdings
GDS
$5.92B
| $144M | 0.36% |
1,801,700
-112,200
| -6% | -$6.94M |
|
57
Zoetis
ZTS
$32.9B
| $142M | 0.35% |
1,036,788
-29,924
| -3% | -$3.91M |
|
58
PagSeguro Digital
PAGS
$2.68B
| $141M | 0.35% |
3,977,964
-52,071
| -1% | -$1.47M |
|
59
uniQure
QURE
$2.68B
| $140M | 0.35% |
3,100,307
+169,429
| +6% | +$10M |
|
60
Verisk Analytics
VRSK
$28.7B
| $139M | 0.34% |
818,822
-33,400
| -4% | -$5.28M |
|
61
Bank of America
BAC
$435B
| $137M | 0.34% |
5,778,176
+462,887
| +9% | +$10.9M |
|
62
T-Mobile US
TMUS
$195B
| $134M | 0.33% |
1,290,872
+9,140
| +0.7% | +$876K |
|
63
Tandem Diabetes Care
TNDM
$1.23B
| $133M | 0.33% |
1,349,332
-77,569
| -5% | -$6.19M |
|
64
Newmont
NEM
$94.1B
| $132M | 0.33% |
2,137,306
-5,889
| -0.3% | -$349K |
|
65
BCE
BCE
$20.5B
| $131M | 0.32% |
3,143,058
-136,607
| -4% | -$5.62M |
|
66
JPMorgan Chase
JPM
$930B
| $131M | 0.32% |
1,395,625
-58,595
| -4% | -$5.56M |
|
67
Canadian Imperial Bank of Commerce
CM
$107B
| $130M | 0.32% |
3,876,188
-167,252
| -4% | -$5.22M |
|
68
Procter & Gamble
PG
$338B
| $128M | 0.32% |
1,071,498
-343,197
| -24% | -$40M |
|
69
Regions Financial
RF
$26.6B
| $128M | 0.32% |
11,500,379
+1,450,305
| +14% | +$15.4M |
|
70
Broadcom
AVGO
$1.78T
| $124M | 0.31% |
3,931,140
+51,690
| +1% | +$1.45M |
|
71
Workday
WDAY
$40.9B
| $124M | 0.31% |
660,905
-34,770
| -5% | -$5.62M |
|
72
National Grid
NGG
$79.8B
| $119M | 0.29% |
2,207,520
-113,147
| -5% | -$5.73M |
|
73
Trane Technologies
TT
$99.6B
| $118M | 0.29% |
1,321,691
-27,091
| -2% | -$2.36M |
|
74
GoDaddy
GDDY
$13.6B
| $116M | 0.29% |
1,588,672
+394,065
| +33% | +$28.3M |
|
|
B
75
Barrick Mining
B
$59.6B
| $116M | 0.29% |
4,310,900
| – | – |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.